Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Beth Cronin's research focuses on health sciences and medical education, with a particular emphasis on obstetrics and gynecology, reproductive health, and the impact of medical treatments on cognition and the gut microbiome. She has investigated racial and ethnic differences in trainee experiences within obstetrics and gynecology, and the outcomes of postplacental intrauterine device insertion programs. Her work also explores the use and effectiveness of vaginal estrogen therapy among transgender and nonbinary individuals, as well as emergency contraception preferences in this population. Cronin has published on the implications of chemotherapy regimens, such as cyclophosphamide, methotrexate, and 5-fluorouracil, and doxorubicin, cyclophosphamide, and paclitaxel, on hippocampal-dependent cognition and the gut microbiome. Her scholarship metrics include an h-index of 11, 46 total publications, and 667 total citations. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Christa Corley, Vijayalakshmi Sridharan, Chase Swinton, and Michael S. Robeson.
Metrics
- h-index: 11
- Publications: 46
- Citations: 667
Selected Publications
-
Changes in gut, microbiome, and cognition after doxorubicin, cyclophosphamide, and paclitaxel chemotherapy treatment (2026)
-
Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome (2025)
Collaboration Network
Top Collaborators
- Transmasculine and Gender Nonbinary Individuals’ Assigned Female at Birth Experiences and Preferences With Emergency Contraception [ID 1366]
- Vaginal estrogen therapy among transgender and nonbinary assigned female at birth individuals: use, effectiveness, and hesitations
- Transmasculine and Gender Nonbinary Individuals’ Assigned Female at Birth Experiences and Preferences With Emergency Contraception [ID 1366]
- Vaginal estrogen therapy among transgender and nonbinary assigned female at birth individuals: use, effectiveness, and hesitations
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
- ACR Appropriateness Criteria® Transgender Breast Cancer Screening
Similar Researchers
Based on overlapping research topics